Uptake and Intracellular Fate of Surface-Modified Gold Nanoparticles
Source abstract
Abstract
Understanding and controlling the interactions between nanoscale objects and living cells is of great importance for arising diagnostic and therapeutic applications of nanoparticles and for nanotoxicology studies. Here we report a detailed transmission electron microscopy (TEM) study of the uptake of ca. 16 nm surface-modified gold nanoparticles by human fibroblast cells (HeLa cells). It is demonstrated that the well-established endosomal route of cellular uptake can be bypassed to a significant extent by controlling the uptake mechanism either via the delivery of the nanoparticles by liposomes or by surface modification of the nanoparticles with so-called cell penetrating peptides (CPPs). Successful nuclear targeting is demonstrated using surface modification with a cocktail of CPPs and a peptide acting as a nuclear localization signal (NLS).
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced biosensing and bioanalysis techniques · RNA Interference and Gene Delivery · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry, University of Liverpool, Liverpool L69 7ZD, United Kingdom
The Physiological Laboratory, University of Liverpool, Liverpool L69 3BX, United Kingdom
References (31)
Show source-provided references
1. Luccardini C. · J. Biomed. Biotechnol. · 2007 · 2007 · 110.1155/2007/68963 ↗
2. Parak W. J. · Nanotechnology · 2005 · 16 · R910.1088/0957-4484/16/2/R01 ↗
3. Alivisatos A. P. · Annu. Rev. Biomed. Eng. · 2005 · 7 · 5510.1146/annurev.bioeng.7.060804.100432 ↗
4. El-Sayed I. H. · Cancer Lett. · 2006 · 239 · 12910.1016/j.canlet.2005.07.035 ↗
5. Hainfeld J. F. · Phys. Med. Biol. · 2004 · 49 · N30910.1088/0031-9155/49/18/N03 ↗
6. El-Sayed I. H. · Nano Lett. · 2005 · 5 · 82910.1021/nl050074e ↗
7. Sandhu K. K. · Bioconjugate Chem. · 2002 · 13 · 310.1021/bc015545c ↗
8. Koo O. M. · Nanomed.: Nanotechnol., Biol. Med. · 2005 · 1 · 19310.1016/j.nano.2005.06.004 ↗
9. Yguerabide J. · Anal. Biochem. · 1998 · 262 · 13710.1006/abio.1998.2759 ↗
10. Yguerabide J. · Anal. Biochem. · 1998 · 262 · 15710.1006/abio.1998.2760 ↗
11. Lasne D. · Biophys. J. · 2006 · 91 · 459810.1529/biophysj.106.089771 ↗
12. Fu A. · Nano Lett. · 2007 · 7 · 17910.1021/nl0626434 ↗
13. Bruchez M. · Science · 1998 · 281 · 201310.1126/science.281.5385.2013 ↗
14. Hayat M. · 1989 · 1
15. Lewin M. · Nat. Biotechnol. · 2000 · 18 · 41010.1038/74464 ↗
16. Jun Y. W. · J. Am. Chem. Soc. · 2005 · 127 · 573210.1021/ja0422155 ↗
17. Möbius W. · Traffic · 2003 · 4 · 22210.1034/j.1600-0854.2003.00072.x ↗
18. De la Fuente J. M. · Bioconjugate Chem. · 2005 · 16 · 117610.1021/bc050033+ ↗
19. Tkachenko A. G. · J. Am. Chem. Soc. · 2003 · 125 · 470010.1021/ja0296935 ↗
20. Tkachenko A. G. · Bioconjugate Chem. · 2004 · 15 · 48210.1021/bc034189q ↗
21. Oyelere A. K. · Bioconjugate Chem. · 2007 · 18 · 149010.1021/bc070132i ↗
22. Turkevich J. · Discuss. Faraday Soc. · 1951 · 11 · 5510.1039/df9511100055 ↗
23. Frens G. · Nature-Phys. Sci. · 1973 · 241 · 2010.1038/physci241020a0 ↗
24. Chithrani B. D. · Nano Lett. · 2006 · 6 · 66210.1021/nl052396o ↗
25. Kanaras A. G. · Chem. Commun. · 2002 · 229410.1039/b207838b ↗
26. Lévy R. · J. Am. Chem. Soc. · 2004 · 126 · 1007610.1021/ja0487269 ↗
27. Hong R. · J. Am. Chem. Soc. · 2006 · 128 · 107810.1021/ja056726i ↗
28. Pelkmans L. B. · Cell · 2004 · 118 · 76710.1016/j.cell.2004.09.003 ↗
29. Lundberg P. · Int. J. Pept. Res. Ther. · 2006 · 12 · 10510.1007/s10989-005-9007-y ↗
30. Patel L. N. · Pharm. Res. · 2007 · 24 · 197710.1007/s11095-007-9303-7 ↗
31. Foerg C. · J. Pharm. Sci. · 2008 · 97 · 14410.1002/jps.21117 ↗